SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19
SARS-CoV-2 감염은 COVID-19의 초기 중등도 단계에서 가용성 혈소판 활성화 마커 및 PAI-1을 유도합니다
Article
[키워드] activated
activated partial thromboplastin time
activation of platelet
activation of platelets
Analysis
aPTT
CD40 ligand
Coagulation
coagulation dysfunction
coagulation factor
Coagulation factors
Coagulation system
coagulation test
coagulation tests
Comorbidity
correlated
COVID-19
COVID-19 patient
COVID-19 patients
COVID-19 severity
D-dimer
dysfunction
dysregulated
elevated
Factor
fibrinogen
flow cytometry
FXIII
help
hospitalized COVID-19 patient
hospitalized COVID-19 patients
induce
inhibitor
intensive care
limit
marker
moderate
Moderate COVID-19
molecular
Multiplex assay
P-selectin
partial thromboplastin time
Pathogenesis
pathogenesis of COVID-19
pathway
performed
plasma
plasminogen
Platelet
platelet activation
Platelets
Pneumonia
progression
prothrombin
Prothrombin time
recruited
reduction in
required
SARS-COV-2 infection
severe cases
severe COVID-19
severe patients
severity
significantly
Stage
TFPI
the disease
Thromboembolism
THROMBOPLASTIN
Thromboprophylaxis
tissue
Tissue Factor
tissue factor pathway inhibitor
tissue plasminogen activator
[DOI] 10.1111/ijlh.13829 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/ijlh.13829 PMC 바로가기 [Article Type] Article